Surgical Resection Lowers Oxidative Stress Markers in Patients With Colorectal Cancer
1 other identifier
interventional
60
1 country
1
Brief Summary
Study of Oxidative stress Markers (F2 Isoprostanes for lipid peroxidation, Carbonyl groups for protein peroxidation, 3 Nitrotyrosine for damage by nitrogens, and 8-Hydroxyguanosine for RNA peroxidation)in patients with colorectal cancer undergo surgical treatment (preoperatively during the intervention and postoperatively) and controls.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable colorectal-cancer
Started May 2009
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2011
CompletedFirst Submitted
Initial submission to the registry
November 5, 2011
CompletedFirst Posted
Study publicly available on registry
November 11, 2011
CompletedNovember 11, 2011
November 1, 2011
1.4 years
November 5, 2011
November 10, 2011
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Comparison of Oxidative stress markers in patients with colorectal cancer and controls
Oxidative stress markers variation (8-PGF2α, Protein Carboyls, 3-Nitrotyrosine, 8-OHG) during and after surgery for colorectal cancer, and compare with controls
up to 2 years
Secondary Outcomes (1)
Validation of oxidative stress markers in patients with colorectal cancer undergo surgical resection
up to 2 years
Study Arms (2)
Surgery for colorectal cancer
OTHERColorectal cancer patients
Controls
NO INTERVENTIONControls
Interventions
Surgical resection of colorectal cancer
Eligibility Criteria
You may qualify if:
- Patients with colorectal cancer
- Controls
You may not qualify if:
- ASA\>3
- Metastatic Disease
- Acute bowel obstruction
- Acute bowel perforation
- BMI\<30
- Chronic Systemic or Autoimmune Diseases
- Smokers
- Alcohol consumers
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- G. Hatzikosta General Hospitallead
- University of Ioanninacollaborator
Study Sites (1)
G. Hatzikosta General Hospital
Ioannina, Epirus, 45001, Greece
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
George Pappas-Gogos, MD
G. Hatzikosta General Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR
- Intervention Model
- FACTORIAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Head of Department of Surgery, G.Hatzikosta General Hospital
Study Record Dates
First Submitted
November 5, 2011
First Posted
November 11, 2011
Study Start
May 1, 2009
Primary Completion
October 1, 2010
Study Completion
June 1, 2011
Last Updated
November 11, 2011
Record last verified: 2011-11